Implications of long-term culture for mesenchymal stem cells: Ggenetic defects or epigenetic regulation?

Stem Cell Research and Therapy

Volumn 3, Issue 6, 2012, Pages

  Wagner, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CELL CULTURE; CELL EXPANSION; CLONE; DEVELOPMENTAL GENE; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; EPIGENETICS; GENE EXPRESSION; GENETIC DISORDER; HISTONE MODIFICATION; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SENESCENCE; STEM CELL TRANSPLANTATION; TELOMERE; BONE MARROW CELL; CYTOLOGY; FEMALE; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM;

BONE MARROW CELLS; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS;

EID: 84871510918     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt145     Document Type: Review

References (10)

1. From cytogenomic to epigenomic profiles: monitoring the biological behavior of in vitro cultured human bone marrow mesenchymal stem cells. Redaelli S, Bentivegna A, Foudah D, Miloso M, Redondo J, Riva G, Baronchelli S, Dalpra L, Tredici G, Stem Cell Res Ther 2012 3 47 10.1186/scrt138 23168092
2. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Garcia S, Bernad A, Martin MC, Cigudosa JC, Garcia-Castro J, de la Fuente R, Exp Cell Res 2010 316 1648 1650 10.1016/j.yexcr.2010.02.016 20171963
3. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track-letter. Torsvik A, Rosland GV, Svendsen A, Molven A, Immervoll H, McCormack E, Lonning PE, Primon M, Sobala E, Tonn JC, Goldbrunner R, Schichor C, Mysliwietz J, Lah TT, Motaln H, Knappskog S, Bjerkvig R, Cancer Res 2010 70 6393 6396 10.1158/0008-5472.CAN-10-1305 20631079
4. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Tchirkov A, Rouard H, Henry C, Splingard M, Dulong J, Monnier D, Gourmelon P, Gorin NC, Sensebé L, Société Française de Greffe de Moelle et Thérapie Cellulaire, Blood 2010 115 1549 1553 10.1182/blood-2009-05-219907 20032501
5. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Schellenberg A, Lin Q, Schueler H, Koch C, Joussen S, Denecke B, Walenda G, Pallua N, Suschek C, Zenke M, Wagner W, Aging (Albany NY) 2011 3 873 888
6. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montagna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F, Cancer Res 2007 67 9142 9149 10.1158/0008-5472.CAN-06-4690 17909019 (Pubitemid 47535900)
7. Pluripotent stem cells escape from senescence-associated DNA methylation changes. Koch CM, Reck K, Shao K, Lin Q, Joussen S, Ziegler P, Walenda G, Drescher W, Opalka B, May T, Brummendorf TH, Zenke M, Saric T, Wagner W, Genome Res 2012
8. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W, Aging Cell 2010 9 54 63 10.1111/j.1474-9726.2009.00535.x 19895632
9. Monitoring of cellular senescence by DNA-methylation at specific CpG sites. Koch CM, Joussen S, Schellenberg A, Lin Q, Zenke M, Wagner W, Aging Cell 2012 11 366 369 10.1111/j.1474-9726.2011.00784.x 22221451
10. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Lapasset L, Milhavet O, Prieur A, Besnard E, Babled A, Ait-Hamou N, Leschik J, Pellestor F, Ramirez JM, De VJ, Lehmann S, Lemaitre JM, Genes Dev 2011 25 2248 2253 10.1101/gad.173922.111 22056670